Kiniksa Pharmaceuticals Ltd（KNSA）价格预测KNSAKiniksa Pharmaceuticals Ltd

Alphio's KNSA stock price prediction model matches the current Kiniksa Pharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $72.89 (-0.13%). The 1-week path is $72.95 (-0.04%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Kiniksa Pharmaceuticals Ltd appears to be a good buy right now due to its strong revenue growth and positive analyst ratings. The current price is $76.73, with a recent revenue of $243.6 million for Q2, reflecting a 55% year-over-year increase. Additionally, the forward P/E ratio is 59.52, indicating growth potential despite current volatility. The main risk is the RSI at 37.99, suggesting potential oversold conditions.

Kiniksa Pharmaceuticals Ltd (KNSA) last closed at $72.9800034, losing -4.89%. These facts feed the 1-day and 1-week KNSA price prediction above.